Identifying versatile inhibitors of metastasis that operate in multiple sites against distinct cancer cell types is important for designing novel therapeutics for metastasis. We show that multiple tissues of timp-3 À/À mice are more susceptible to metastatic colonization. Overall, a 5-14-fold increase in liver and kidney colonization occurred by EL-4 lymphoma cells, and a twofold increase upon targeting B16F10 melanoma cells to the bone or lung of timp-3 À/À mice. There was a general lack of macrophage or neutrophil localization to metastases in the liver, kidney and lung, and of osteoclasts to bone in both genotypes. Analysis of lung showed that proliferation or angiogenesis were unaltered within the metastatic colonies. Lung-trap assays revealed that initial tumor cell trapping was similar in the lung vasculature of timp-3 À/À and wild-type mice. However, more tumor cells were found in timp-3 À/À lungs at 48 and 96 h after tumor cell injection indicating more efficient extravasation and initial proliferation. Activation of pro-MMP-2 was greater in timp-3 À/À lungs at these time points. These data demonstrate TIMP-3 functions to inhibit metastatic dissemination of diverse cancer cells to multiple organs. TIMP-3 regulates MMP-2 activation to limit tumor cell extravasation and subsequent colonization of the lung, without augmenting inflammatory cell response.
Introduction
Effective treatment of metastasis remains the most challenging aspect of cancer therapy. Proteolytic remodeling of the extracellular matrix (ECM) facilitates multiple stages of cancer dissemination including tumor angiogenesis, invasion, migration, extravasation and colonization of secondary site (Chang and Werb, 2001 ). The common sites of metastasis for solid tumors are the lung, liver, bone and brain, whereas lymphomas frequently affect the kidney (Urban and Fishman, 2000; Perez et al., 2001) . These tissues have specific morphology, cellular and ECM composition, and levels of growth factors and cytokines, and provide a distinct 'soil' for the metastatic cancer cells. Identification of endogenous protease inhibitors that operate at multiple sites and their mechanisms of action are important steps toward developing therapeutic strategies for metastasis.
Tissue inhibitor of metalloproteinase 3 (TIMP-3) is sequestered to the ECM and has broad metalloproteinase inhibitory activity against members of the matrix metalloproteinase (MMP), a disintegrin and metalloproteinases (ADAM), and ADAM with thrombospondin domain (ADAM-TS) families (Woessner, 2001 ). These are key enzymes for cleaving ECM proteins through MMP activity, shedding cell surface proteins by ADAMs, and processing proteoglycans by ADAM-TS; all events that contribute to metastatic dissemination (Chang and Werb, 2001) . TIMP-3 is highly expressed in several organs commonly affected in human cancers (Leco et al., 1994; Nuttall et al., 2004) . Clinical studies report silencing of TIMP-3 in a number of human cancers, and its reduction in stroma surrounding invasive colorectal cancers (Powe et al., 1997) . On the other hand, TIMP-3 is highly expressed in invasive esophageal adenocarcinoma and melanoma (Airola et al., 1999; Salmela et al., 2003) . Genetic manipulation of TIMP-3 expression significantly affects the primary tumor at the levels of tumor invasion, angiogenesis and growth. Its overexpression in tumor cell lines inhibits, (Ahonen et al., 1998; Spurbeck et al., 2002) , whereas its ablation in the host stroma promotes these processes (Cruz-Munoz et al., 2006) . In addition to affecting ECM degradation, loss of TIMP-3 affects cytokine homeostasis (Mohammed et al., 2004; Kassiri et al., 2005) . Cytokinemediated inflammation is now recognized to be important in tumor development (Coussens and Werb, 2002) , although its role in metastasis is currently not well understood. Thus, TIMP-3 is an important modulator of tumorigenesis that may also play a fundamental role in determining the tissue susceptibility to metastasis.
We investigated whether TIMP-3 deficiency affected metastasis of distinct cancer cell types to multiple organs. Metastatic dissemination of melanoma and lymphoma were targeted to specific sites in timp-3 À/À mice and their wild-type littermates. We found that a lack of TIMP-3 in the host leads to 2-14-fold increase in metastasis to organs that are commonly affected by metastasis in human cancers.
Results
Timp-3 deficiency confers metastatic susceptibility to kidney TIMP-3 is differentially expressed in a number of organs some of which are common targets of metastasis in human cancers. The timp-3 À/À mouse presented an ideal opportunity to test metastatic susceptibility of multiple tissues. Intracardial administration delivered the murine melanoma B16F10 cell line to tissues downstream of arterial outflow. We examined the brain, kidney, adrenal, bone and pancreas for metastatic colonization. Table 1 shows that all timp-3 À/À kidneys and four of the five timp-3 À/À brains had metastatic colonies, whereas none of the six wild-type kidneys and only one of the six wild-type brains were positive. On the other hand, pancreas and adrenals were similarly affected in the two genotypes. The kidney expresses the highest levels of TIMP-3 among the mouse organs. The brain and adrenals have moderate, whereas the pancreas has a lower level of TIMP-3 expression (Leco et al., 1994) . This suggested that timp-3 deficiency allowed metastatic colonization of the kidney and brain, which remained largely unaffected by melanoma cells in wild-type mice. Although useful in determining the overall susceptibility of various organs to B16F10 melanoma cell, intracardial injections presented a limitation. Specifically, many mice succumbed to hindlimb paralysis owing to bone metastasis, whereas metastases in other organs were still microscopic. To circumvent this limitation, our approach was to target specific tissues through selected routes of tumor cell administration (intracardial or intravenous) with selected cells lines (EL-4 lymphoma or B16F10 melanoma cells).
Enhanced metastatic colonization of multiple organs in timp-3 À/À mice Lymphoma is known to metastasize the kidney in humans (Urban and Fishman, 2000) . Therefore, we selected EL-4, a murine lymphoma cell line to further study kidney metastasis. This cell line provided the additional advantage of targeting the liver (Ding et al., 2001) . CD3 immunostaining revealed that all mice of both genotypes showed kidney metastases following EL-4 injections, although with a variant degree of colonization (Figure 1) . We further observed a striking enlargement of timp-3 À/À kidneys (5/10 kidneys), which was not seen in the wild-type group (0/9 kidneys) (Figure 1a and b). CD3 immunostaining revealed extensive lymphoma infiltration into timp-3 À/À kidney, compared to far fewer and smaller colonies in wild-type kidney (Figure 1c and  d) . The metastatic foci were present in the cortex and medulla, had poorly defined borders in timp-3 À/À kidney. Tumor cells were found in either peritubular or periglomerular location. In heavily infiltrated kidneys, tumor cells compromised most of the cortex and medulla with occasional invasion into perirenal fat. Next, we assessed EL-4 metastasis in the liver, which has moderate TIMP-3 expression. Timp-3 À/À livers showed multiple tumor foci, which were circumscribed but with poorly defined borders (Figure 1e and f). These foci were predominantly in periportal areas and occasionally in intralobular regions (Figure 1g and h). In contrast, wild-type liver had only single lymphoma cells scattered in the sinusoids with few cells present in periportal regions. Thus, far greater metastatic colonization of both kidney and liver occurred in timp-3 À/À mice by the lymphoma cells.
Bone is one of the three tissues most commonly affected by metastasis in human cancers (Perez et al., 2001) . We asked whether TIMP-3 loss affected bone metastasis. Macroscopic examination of the distal end of femurs indicated melanotic metastases at the time of killing (Figure 1i and j) in both groups. Longitudinal cross-sections showed more extensive bone degradation in the trabecular region in timp-3 À/À femurs compared to wild-types (Figure 1k and l). We also asked whether lung is affected by TIMP-3 deficiency. Lung is the most common site of metastasis by various cancers including colorectal cancer, breast cancer and melanoma (Pastorino et al., 1997) . TIMP-3 is highly expressed in the lung, and lungs of timp-3 À/À mice display abnormalities at old age, following heart disease and during bronchiole branching morphogenesis (Leco et al., 2001; Gill et al., 2003; Kassiri et al., 2005) . We observed a higher number of melanoma colonies on the lung surface of timp-3 À/À mice (Figure 1m and n). Lung cross-sections revealed multiple foci, predominantly in perivascular and subpleural areas with the occasional invasion into pleural space. These foci sometimes invaded parenchyma and airways, were variable in pigmentation and showed minimal necrosis (Figure 1o and p). Overall, the loss of timp-3 led to an enhancement of metastatic colonization in all four organs tested, three of which are common targets of metastasis in human cancers. 
Each number denotes an independent mouse and '+' indicates the presence of metastasis in the listed organ. Presence of metastasis was determined by microscopic examination of H/E-stained tissue sections.Abbreviations: H/E, hematoxylin/eosin.
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Metastatic load is 2-14-fold greater in timp-3 À/À organs CD3 þ immunostaining showed a 14-fold increase in timp-3 À/À kidney compared to wild-types (0.2270.09 vs 0.0170.00, P ¼ 0.035; Figure 2a ), and fivefold increase in timp-3 À/À liver (0.0370.01 vs 0.0070.00, P ¼ 0.002; Figure 2b ). Thus, the burden of lymphoma metastasis was significantly higher in the kidney and liver upon loss of TIMP-3.
Bone presented a challenging scenario for determination of metastatic burden because sectioning of this tissue typically results in specific loss of bone marrow and metastatic cells. We rationalized that bone osteolysis arising from metastatic colonization provides a surrogate measure of metastasis. Femurs from timp-3 À/À mice had a 1.8-fold decrease in bone content compared to wild-type mice (0.2770.02 vs 0.1570.01; P ¼ 0.001, Figure 2c ). Next, we quantified B16F10 melanoma in the lung. Owing to the extensive metastases on the lung surface, only six of 13 timp-3 À/À lungs and 10 of 13 wild-type lungs could be accurately measured. This analysis showed twofold increase in lung metastases to timp-3 À/À mice compared to wild-type littermates (205736 vs 99725; P ¼ 0.032, Figure 2d ). To quantify the metastatic load in the entire group, we performed histomorphometric analysis in hematoxylin/eosin (H/E)-stained lung sections, which showed increased B16F10 metastatic burden in timp-3 À/À mice (0.3870.05 vs 0.2170.06; P ¼ 0.024, Figure 2e ). Overall, all of the Enhanced metastatic dissemination to multiple organs W Cruz-Munoz et al
timp-3
À/À organs examined had a significant increase in metastatic burden.
Lack of inflammatory cell involvement in metastasis of timp-3
À/À tissues Increased tumor necrosis factor (TNF) bioactivity in timp-3 À/À mice leads to hepatic inflammation (Mohammed et al., 2004) , and accelerated progression to heart failure in a model of heart disease (Kassiri et al., 2005) . Inflammation plays a role in tumorigenesis, and infiltrating macrophages can affect metastasis (Lin et al., 2001) . We asked whether the enhanced metastasis to multiple sites in timp-3 À/À mice resulted from altered inflammatory response in these organs. F4/80 immunostaining was used to detect macrophage in metastasesbearing kidney and liver (Figure 3a and c). Macrophages were found scattered throughout these tissues, without any preferential localization to the metastatic foci. Histomorphometric analyses of timp-3 À/À and wild-type metastases-bearing kidney and liver showed no significant difference in the number of macrophage present in these tissues (Figure 3b and d, P ¼ 0.65 and 0.25, respectively). Further, immunostaining of kidney and liver sections for Mac-3, as a marker for activated macrophages, showed no consistent difference between the two genotypes (data not shown). Macrophages belong to the monocytic lineage, which is also responsible for generating osteoclast. Osteoclasts are important mediators of osteolysis and can be activated by B16 melanoma cells (Perez et al., 2001; Mundy, 2002) . We determined whether the higher level of osteolysis in B16F10-bearing timp-3 À/À bones was due to increased osteoclast population. TRAP staining showed the presence of osteoclasts at the end of the growth plate, trabecular region and in the compact bone ( Figure 3e ) in both timp-3 À/À and wild-type metastasesbearing bones, with no significant difference in the two groups (Figure 3f , P ¼ 0.81). As in the case of kidney and liver, F4/80 immunostaining of metastases-bearing lungs also showed no significant difference between timp-3 À/À and wild-type mice (Figure 3g and h, P ¼ 0.89). Overall, the numbers of monocytic cells, macrophage and osteoclasts, are not altered within metastases of timp-3 À/À organs, ruling out a general upregulation of the inflammatory response during metastasis in TIMP-3-deficient mouse.
Proliferation and angiogenesis remain unaltered within metastatic foci in timp-3 À/À lung We focused on melanoma colonization of the lung as a model system to further characterize the cellular mechanisms responsible for the enhanced metastasis in timp-3 À/À tissues. Melanoma metastases arise as isolated foci making immunohistological quantification feasible, in contrast to lymphoma metastases that present as mosaic colonization. Lungs were examined for neutrophil infiltration as these cells can enhance tumor cell invasion (Shamamian et al., 2001; De Larco et al., 2004) . However, minimal neutrophil presence and lack of their association with metastases in timp-3 À/À and wild-type Enhanced metastatic dissemination to multiple organs W Cruz-Munoz et al lungs was observed (Figure 4a ). We have recently reported that B16F10 melanomas grown as subcutaneous tumors in timp-3 À/À mice have enhanced angiogenesis (Cruz-Munoz et al., 2006). We therefore determined angiogenesis within the metastatic foci, restricting our analysis to foci of comparable size in the two groups. Histomorphometry of vWF stained lung sections showed no difference in angiogenesis of the colonies in timp-3 À/À and wild-type hosts (Figure 4b and c, P ¼ 0.84). We next determined whether tumor cell proliferation was altered in metastatic foci of similar size. Ki67 immunostaining indicated no significant difference in the percentage of proliferating tumor cells (Figure 4d and e, P ¼ 0.66) in timp-3 À/À and wild-type lung metastases. These results indicate that neither angiogenesis nor tumor cell proliferation was the prominent mechanism for enhanced B16F10 lung metastasis in timp-3 À/À mice.
Enhanced extravasation of melanoma cells in timp-3
À/À lungs A cascade of events is involved in experimental metastasis. Tumor cell extravasation from the vasculature into tissue parenchyma is one of the initial steps in this process. We performed lung-trap assays in which injected tumor cells are retrieved from the lung at specific time points and measured by plating efficiency. Using real-time imaging of experimental metastasis, Cameron et al. (2000) have shown active B16F10 cell extravasation in the mouse lung at 48 h and cell proliferation starting at 96 h after tumor cell injection. We chose sampling time points of 15 min representing the initial trapping of tumor cells in the lung vasculature, as well as 48 and 96 h for extravasation and proliferation, respectively. The plating efficiency of Enhanced metastatic dissemination to multiple organs W Cruz-Munoz et al B16F10 cells at 15 min post-injection did not differ between timp-3 À/À and wild-type mice (14907397 vs 8427161; Figure 5 , P ¼ 0.23), suggesting that a similar number of tumor cells were arrested in the lung vasculature of both genotypes of mice. There was, however, a more than eightfold increase in plating efficiency of timp-3 À/À over wild-type lung homogenates at 48 h post-injection (79726 vs 979; P ¼ 0.048). This difference became more pronounced at 96 h (3127129 vs 1879; P ¼ 0.004, Figure 5 ). Thus, enhanced extravasation of B16F10 melanoma cells into timp-3 À/À lung stroma is responsible, at least in part, for increased metastatic load in timp-3 À/À lungs.
Increased pro-MMP-2 activation in timp-3 À/À lungs Among the many MMPs promoting invasion and metastasis, cell surface activation of MMP-2 through MT-1MMP has emerged to be critical for this process (Itoh et al., 1998; Hofmann et al., 2000 Hofmann et al., , 2005 . Our recent studies show that timp-3 À/À mouse embryonic fibroblasts have accelerated MT1-MMP-dependent pro-MMP-2 activation (English et al., 2006) . We asked whether increased extravasation of B16F10 cells in timp-3 À/À lungs associated with increased MMP-2 activation. Zymography revealed a much higher level of MMP-9 activity at 15 min post-injection compared to the later time points and to the untreated lungs. However, MMP-9 activity remained comparable between the two genotypes throughout the course of the experiment. In contrast, active MMP-2 species were primarily seen in timp-3 À/À lung tissues especially at 48 and 96 h, whereas pro-MMP-2 levels remained comparable between timp-3 À/À and wild-type metastases-bearing lungs (Figure 6a ). Densitometric quantification of these bands confirmed the greater levels of active MMP-2 in timp-3 À/À lung homogenates (data not shown). Thus, MMP-2 activation was far more pronounced in timp-3 null lungs at the time points corresponding to active extravasation and proliferation of B16F10 cells.
Discussion
MMPs and their tissue inhibitors are important factors in tumor cell invasion and metastasis. However, little direct evidence exists to support the inhibitory role of TIMPs in host stroma against metastasis. We show here that several sites commonly affected by metastasis in human cancers are more prone to metastatic colonization in the absence of host TIMP-3. Specifically, when challenged with melanoma or lymphoma cells, a timp-3 À/À deficiency leads to 2-14-fold increase in metastatic burden in the lung, bone, liver and kidney. TIMP-3 expression is most abundant in the kidney (Leco et al., 1994) , and the increased metastatic colonization of timp-3 À/À kidney was the highest among all tissues examined. Inflammatory cell infiltration or their association with metastatic cells is not altered during metastatic colonization of these organs. Similarly, proliferation or angiogenesis within metastatic foci remain unaltered in timp-3 À/À lung. Increased tumor cell extravasation, but not trapping in the lung vasculature, of melanoma cells occurs in timp-3 À/À lung coinciding with increased MMP-2 activation. Our study provides the first direct evidence for an inhibitory role of host stromal timp-3 À/À during metastatic colonization.
TIMPs are secreted proteins, and TIMP-3 is uniquely ECM-bound (Yu et al., 2000) . Decreased TIMP-3 expression in the stroma adjacent to highly aggressive colorectal adenocarcinomas is thought to allow increased local invasion (Powe et al., 1997) . Tumor cells at the invasive front of esophageal squamous carcinoma also lack TIMP-3, which correlates with increased depth of tumor invasion and number of lymph node metastases (Miyazaki et al., 2004) . Consistent with this, our study shows more efficient tumor cell extravasation into timp-3-deficient lung. B16 melanoma cells produce significant levels of MMP-2 and MT1-MMP, which have been shown to localize at the tumor-stroma border and enhance their invasive potential (Banerji et al., 2004; Hofmann et al., 2005) . The MMP-2 activation seen at 48 h, which is the period of B16F10 cell extravasation, may be particularly important in facilitating extravasation of these cells across the basement membrane in timp-3 À/À lung. Notably, we have recently reported that timp-3 plays a significant role in the inhibition of pro-MMP-2 activation by comparing mouse embryo Enhanced metastatic dissemination to multiple organs W Cruz-Munoz et al fibroblasts deficient in each of the four timp genes (English et al., 2006) . In contrast to timp-3
mice show no difference in their lung colonization when challenged with tumorigenic cells in experimental metastasis assays (Soloway et al., 1996) . We propose that unlike TIMP-1, ECM localized TIMP-3 serves a distinct role in regulating tumor cell extravasation through the basement membrane and stroma. Both TIMP-2 and TIMP-4 are also expressed in mouse lung. Although, TIMP-2 is an important regulator of pro-MMP-2 activation, there is no published evidence of altered tumor cell metastasis in timp-2-deficient mice.
Whether the ablation of timp-4 affects lung colonization is the focus of ongoing studies in our lab. Distinct cancer cell types, melanoma and lymphoma, are more efficient at colonizing timp-3 À/À -deficient tissues. It is likely that similar to melanoma, higher MMP activity also plays a role in the increased extravasation of lymphoma cells in timp-3 À/À livers. We have reported that timp-3 À/À liver has constitutive release of TNF-a and activation of its signaling pathway (Mohammed et al., 2004) , and it is likely that TNF-a contribute to the metastatic process in timp-3 À/À liver. Tumor cells are known to upregulate TNF-a, which in turn increases endothelial cell expression of adhesion molecules (e.g. P-selectin, E-selectin and VCAM-1) that facilitate tumor cell interaction with the endothelium leading to extravasation (Khatib et al., 1999; Ding et al., 2001; Kitakata et al., 2002) . The higher hepatic TNF-a levels in timp-3 À/À mice may upregulate adhesion molecules and the attachment of EL-4 lymphoma cells to hepatic endothelium, facilitating extravasation. The importance of adhesion molecules during EL-4 metastases is underscored by reduced liver metastasis of these cells in P-selectin-deficient mice (Ding et al., 2001) . Overall, the loss of host TIMP-3 impacts proteases as well as cytokines that are known to affect metastatic efficiency of diverse cancer cell types.
We postulate that individual timp-3-deficient organs will involve diverse mechanisms during metastatic colonization. Unlike liver, the levels of constitutive TNF-a do not differ between timp-3 À/À and wild-type kidney (Mohammed et al., 2004) ; however, it remains possible that TNF-a levels rise when metastatic cells interact with the timp-3 À/À kidney endothelium. With respect to bone, timp-3 deficiency may allow greater release of cytokine and growth factors to promote metastatic growth. Bone matrix contains a number of osteoblast-associated factors that not only stimulate proliferation of endogenous bone cells, but also of tumor cells (Orr et al., 1993) . For instance, the release of membrane-bound RANKL by MT1-MMP and ADAM-17 enhances its availability for RANK-receptor and activation of osteoclasts (Lum et al., 1999) . Higher MT1-MMP activity in timp-3 À/À tissue, as reflected by MMP-2 activation, could result in greater osteoclast activation and osteolysis. Although we have observed increased osteolysis of timp-3 À/À bones, we did not find any increase in the number of osteoclasts in metastasesbearing bone at the late stage of colonization. The molecular mechanisms that contribute to the enhanced metastatic colonization of the kidney and bone in timp-3 À/À mice remain to be further studied. An important consideration in determining the specific mechanisms responsible for this outcome is the potential effect of TIMP-3 lack on ECM development. Thus far, aged timp-3 À/À mice have enhanced air space enlargement and decreased lung function associated with decreased collagen (Leco et al., 2001) . Embryonic timp-3
À/À lung also shows decreased bronchiolar branching and terminal buds with dilated ends (Gill et al., 2003) . Whether these abnormalities impact the process of metastasis remains open. It is also important to determine whether increased metastasis in timp-3 null organs can be reversed by strategies that reconstitute or overexpress this protein.
Metastasis, the primary cause of cancer mortality, still remains a major biomedical challenge. Given that B60% of cancer patients present metastasis (Castells and Rutsgi, 2003) , it is imperative to understand the mechanisms that underlie tumor cell dissemination and growth at secondary sites. Our study shows that the loss of murine timp-3 gene profoundly impacts the metastasis susceptibility of multiple tissues that are commonly afflicted in human cancers. A better understanding of timp-3 inhibitory function in metastasis may eventually translate into novel strategies to target tumor cell dissemination.
Materials and methods
Experimental metastasis assays C57/Bl6-syngeneic EL-4 lymphoma or B16F10 melanoma cell lines were injected into 8-12 weeks old timp-3 À/À and wild-type mice maintained in the C57/Bl6 background. The specific cell line and the route of tumor cell administration differed depending on the organ to be targeted. Intracardial injections were used to deliver EL-4 cells (1 Â 10 5 ) to the kidney and liver, and B16F10 cells (5 Â 10 4 ) to bone as described (SanchezSweatman et al., 1997) . Lungs were targeted via intravenous administration of B16F10 cells (1.25 Â 10 5 ). Injections were blinded with respect to the genotype of the mice. Mice were killed 12 after EL-4 injections or 14 days after B16F10 injections, and tissues fixed in 10% formalin.
Immunohistology and histomorphometry
Kidney and liver tissue sections bearing EL-4 metastases were stained for mouse CD3 to identify the lymphoma cells and histomorphometry performed as described (Cruz-Munoz et al., 2006) by scoring an entire tissue section for the positive signal. Sections were also stained for F4/80, a macrophage marker and Mac-3, a marker for activated macrophages. Femurs bearing B16F10 cells were decalcified, and longitudinal sections were stained with H/E. Bone content was quantified in the distal end of femurs affected by melanoma colonization. The right lung of mice subjected to B16F10 intravenous injections were sectioned longitudinally, H/E stained and tumor content assessed. Lung sections were immunostained for vWF (endothelial cell marker), F4/80, Ki67 (proliferation marker), and neutrophil-specific antigen. Osteoclast staining was performed using (TRAP)-leukocyte acid phosphatase acid kit (Sigma, St Louis, MO, USA). The number of osteoclasts present within 1 mm of the end of growth plate was Enhanced metastatic dissemination to multiple organs W Cruz-Munoz et al determined. All quantifications described above were blinded with respect to genotype of the mice.
Lung-trap assay
The lung-trap assay was performed as described by (Zhang and Hill, 2004) . Timp-3 À/À and wild-type mice were injected intravenously with B16F10 cells and mice were killed at 15 min, 48 and 96 h post-injection. Lysates from lung tissues isolated were prepared by sonication in RIPA buffer and then analysed by gelatin zymography as described previously (Mohammed et al., 2004) . Zymograms were subjected to densitometry and signals representing active and latent MMP-2 bands were quantified using ImageQuant 1.11 software.
Statistical analysis
All data were analysed with the aid of GraphPad PRISM 3.0 and Excel 2000. Data from bone content, and quantification of staining for F/480, vWF factor and osteoclast was analysed by means of unpaired Student's t-test. All other data were analysed by Mann-Whitney U-test. Po0.05 indicated statistical significance.
